Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H17FN6O2S |
Molecular Weight | 364.398 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)NS(=O)(=O)C1=CN=CC(=C1)C2=CN3N=C(N)N=C3C(F)=C2
InChI
InChIKey=RXRZPHQBTHQXSV-UHFFFAOYSA-N
InChI=1S/C15H17FN6O2S/c1-15(2,3)21-25(23,24)11-4-9(6-18-7-11)10-5-12(16)13-19-14(17)20-22(13)8-10/h4-8,21H,1-3H3,(H2,17,20)
Molecular Formula | C15H17FN6O2S |
Molecular Weight | 364.398 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/22544264
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22544264
CZC24832 is a highly selective and potent phosphoinositide 3-kinase γ (PI3Kγ) inhibitor. It dempnstrated efficacy in in vitro and in vivo models of inflammation.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3267 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22544264 |
19.0 nM [Kd] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22544264
10 mg/kg CZC24832 reduced the progression and severity of arthritis in a therapeutic mouse collagen-induced arthritis model.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22544264
CZC24832 was active in PI3Kγ-dependent cellular C5a-induced AKT Ser473 phosphorylation (IC50 = 1.2 μM) and fMLP-induced neutrophil migration assays (IC50 = 1.0 μM)
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:08:18 GMT 2023
by
admin
on
Sat Dec 16 18:08:18 GMT 2023
|
Record UNII |
96ER5DQD27
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
42623951
Created by
admin on Sat Dec 16 18:08:18 GMT 2023 , Edited by admin on Sat Dec 16 18:08:18 GMT 2023
|
PRIMARY | |||
|
1159824-67-5
Created by
admin on Sat Dec 16 18:08:18 GMT 2023 , Edited by admin on Sat Dec 16 18:08:18 GMT 2023
|
PRIMARY | |||
|
DTXSID50655226
Created by
admin on Sat Dec 16 18:08:18 GMT 2023 , Edited by admin on Sat Dec 16 18:08:18 GMT 2023
|
PRIMARY | |||
|
96ER5DQD27
Created by
admin on Sat Dec 16 18:08:18 GMT 2023 , Edited by admin on Sat Dec 16 18:08:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Exhibited 10-fold selectivity over PI3Kβ and >100-fold selectivity over PI3Kα and
PI3Kδ.
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|